Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriela Páchniková is active.

Publication


Featured researches published by Gabriela Páchniková.


Journal of Natural Products | 2014

Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.

Jiří Slanina; Gabriela Páchniková; Martina Čarnecká; Ludmila Koubíková; Lenka Adámková; Otakar Humpa; Karel Šmejkal; Iva Slaninová

The aim of the present study was to determine the structural requirements for dibenzocyclooctadiene lignans essential for P-glycoprotein inhibition. Altogether 15 structurally related lignans isolated from Schisandra chinensis or prepared by modification of their backbone were investigated, including three pairs of enantiomers. P-Glycoprotein inhibition was quantified using a doxorubicin accumulation assay in human promyelotic leukemia HL60/MDR cells overexpressing P-glycoprotein. A preliminary quantitative structure-activity relationship analysis revealed three main structural features involved in P-glycoprotein inhibition: a 1,2,3-trimethoxy moiety, a 6-acyloxy group, and the absence of a 7-hydroxy group. The most effective inhibitors, (-)-gomisin N (1) and (+)-deoxyschizandrin [(+)-2], were selected for further evaluation of their effects. Both these lignans restored the cytotoxic effect of doxorubicin in HL60/MDR cells and when combined with a subtoxic concentration of this compound increased the proportion of G2/M cells significantly, which is a usual response to treatment with this anticancer drug.


Journal of Natural Products | 2014

Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.

Andreas Schinkovitz; Aman Kaur; Ernst Urban; Martin Zehl; Gabriela Páchniková; Yuehong Wang; Nadine Kretschmer; Iva Slaninová; Guido F. Pauli; Scott G. Franzblau; Georg Krupitza; Rudolf Bauer; Brigitte Kopp

Lichens are resilient organisms, known for their unique profiles of secondary metabolites and for exhibiting antioxidative, antibacterial, and cytotoxic effects. Analyzing the cytotoxic potential of Lobaria scrobiculata, a bioassay-guided fractionation strategy yielded seven known metabolites, with two of these compounds, 2 and 3, exhibiting cytotoxicity against HL-60 cells. In order to verify the potential impact of degradation on observed bioactivity, a purity and stability evaluation was conducted. The consistency of results obtained by the water-soluble tetrazolium salt-1 assay and trypan blue cytotoxicity assay was evaluated for selected compounds.


Journal of Veterinary Medical Science | 2017

Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia

Linda Grillová; Ivo Sedláček; Gabriela Páchniková; Eva Staňková; Pavel Švec; Pavla Holochová; Lenka Micenková; Juraj Bosák; Iva Slaninová; David Šmajs

Escherichia albertii is a recently discovered species with a limited number of well characterized strains. The aim of this study was to characterize four of the E. albertii strains, which were among 41 identified Escherichia strains isolated from the feces of living animals on James Ross Island, Antarctica, and Isla Magdalena, Patagonia. Sequencing of 16S rDNA, automated ribotyping, and rep-PCR were used to identify the four E. albertii isolates. Phylogenetic analyses based on multi-locus sequence typing showed these isolates to be genetically most similar to the members of E. albertii phylogroup G3. These isolates encoded several virulence factors including those, which are characteristic of E. albertii (cytolethal distending toxin and intimin) as well as bacteriocin determinants that typically have a very low prevalence in E. coli strains (D, E7). Moreover, E. albertii protein extracts caused cell cycle arrest in human cell line A375, probably because of cytolethal distending toxin activity.


Toxicology in Vitro | 2016

Substituted 2-hydroxy-N-(arylalkyl)benzamide sensitizes cancer cells to metabolic stress by disrupting actin cytoskeleton and inhibiting autophagic flux.

Gabriela Páchniková; Stjepan Uldrijan; Aleš Imramovský; Vladimír Kryštof; Iva Slaninová

N-((R)-1-(4-chlorophenylcarbamoyl)-2-phenylethyl)-5-chloro-2-hydroxybenzamide (Compound 6k), was recently isolated during the preparation of amino acids esters with salicylanilides. We show here that 6k disrupts the dynamics of actin cytoskeleton in human melanoma cells, affecting processes essential for the maintenance and expansion of tumours such as cell adhesion, motility, proliferation, vesicular transport, and autophagic flux. We demonstrated that inhibition of autophagy by 6k increased the sensitivity of melanoma cells to metabolic stress induced by rotenone or nutrient starvation and potentiated the anti-proliferative activity of small molecule multikinase inhibitor sorafenib. Since autophagy plays an important role in survival of cancer cells subjected to chemotherapy, the above mentioned properties are interesting from clinical point of view as 6k could promote metabolic stress within the tumour microenvironment and potentiate the effect of cytostatics in combination therapy.


Archive | 2017

P-glycoprotein inhibition by dibenzocyclooctadiene lignans from Schisandra chinensis

Martina Drabinová; Martina Čarnecká; Gabriela Páchniková; Otakar Humpa; Iva Slaninová; Jiří Slanina


Archive | 2014

Characterisation of dibenzocyclooctadiene lignans involved inmodulation of multidrug resistance in cancer cells

Gabriela Páchniková; Jiří Slanina; Martina Čarnecká; Karel Šmejkal; Iva Slaninová


Archive | 2014

Impact of Lysosomotropism ans Lysosomes on Toxicity of Anti-Cancer Drugs

Gabriela Páchniková; Iva Slaninová


Archive | 2014

Dibenzocyklooktadiénové lignany - nové inhibítorymulti-liekovej rezistencie nádorových buniek

Gabriela Páchniková; Jiří Slanina; Martina Čarnecká; Karel Šmejkal; Iva Slaninová


Archive | 2013

Dibenzocyclooctadiene lignans - compounds interesting for cancer therapy

Gabriela Páchniková; Jiří Slanina; Martina Čarnecká; Ludmila Koubíková; Iva Slaninová


Archive | 2012

Effect of dibenzocyclooctadiene lignans on multidrug resistantpromyelotic leukaemia cells

Gabriela Páchniková; Ludmila Koubíková; Jiří Slanina; Martina Čarnecká; Iva Slaninová

Collaboration


Dive into the Gabriela Páchniková's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karel Šmejkal

University of Veterinary and Pharmaceutical Sciences Brno

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge